Privia Health Group Inc (NASDAQ: PRVA) established initial surge of 4.42% at $23.86, as the Stock market unbolted on Thursday, before settling in for the price of $22.85 at the close. Taking a more long-term approach, PRVA posted a 52-week range of $18.77-$26.51.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 7.98%. Meanwhile, its Annual Earning per share during the time was 7.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.68%. This publicly-traded company’s shares outstanding now amounts to $122.87 million, simultaneously with a float of $114.72 million. The organization now has a market capitalization sitting at $2.93 billion.
Privia Health Group Inc (PRVA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Privia Health Group Inc industry. Privia Health Group Inc’s current insider ownership accounts for 6.73%, in contrast to 93.78% institutional ownership. According to the most recent insider trade that took place on Dec 12 ’25, this organization’s Director sold 13,647 shares at the rate of 25.01, making the entire transaction reach 341,311 in total value, affecting insider ownership by 68,188. Preceding that transaction, on Dec 12 ’25, Company’s EVP & Chief Financial Officer sold 23,887 for 25.03, making the whole transaction’s value amount to 597,892. This particular insider is now the holder of 172,909 in total.
Privia Health Group Inc (PRVA) Earnings and Revenue Records
Privia Health Group Inc’s EPS increase for this current 12-month fiscal period is 19.68% and is forecasted to reach 0.32 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 56.69% through the next 5 years, which can be compared against the 7.98% growth it accomplished over the previous five years trading on the market.
Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators
Let’s observe the current performance indicators for Privia Health Group Inc (PRVA). It’s Quick Ratio in the last reported quarter now stands at 1.67. Alongside those numbers, its PE Ratio stands at $168.03, and its Beta score is 0.83. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.44. Similarly, its price to free cash flow for trailing twelve months is now 26.80.
In the same vein, PRVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.14, a figure that is expected to reach 0.03 in the next quarter, and analysts are predicting that it will be 0.32 at the market close of one year from today.
